News - Amicus Therapeutics Inc.
2009-05-07 15:00:00
Company Remains on Track to Advance Amigal(TM) for Fabry Disease into Phase 3 in Second Quarter CRANBURY, N.J., May 7 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced financial results for the first quarter 2009.
2008-04-24 09:01:27
CRANBURY, N.J., April 24 /PRNewswire-FirstCall/ -- Amicus Therapeutics Inc. , today announced that John F. Crowley, President and Chief Executive Officer, will present a corporate update at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30, 2008, at 2:20 p.m.
2008-01-02 09:00:52
CRANBURY, N.J., Jan. 2 /PRNewswire-FirstCall/ -- Amicus Therapeutics Inc. , today announced that John F.